Nanobiomedicine Q3 Unclaimed
SAGE Publications Ltd
United Kingdom
Nanobiomedicine is a journal indexed in SJR in Biotechnology and Biomedical Engineering with an H index of 16. It is an CC BY-NC Journal with a Double blind peer review review system The scope of the journal is focused on nanomedicine, nanotechnology, biology, bioengineering, drug delivery, nanotoxicology. It has an SJR impact factor of 0,482 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,482.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Biomedical Engineering (Q3)
Biotechnology (Q3)
Price
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,482
SJR Impact factor16
H Index0
Total Docs (Last Year)5
Total Docs (3 years)0
Total Refs15
Total Cites (3 years)5
Citable Docs (3 years)2
Cites/Doc (2 years)0.0
Ref/DocOther journals with similar parameters
Letters in Applied Microbiology Q3
Molecular Biotechnology Q3
Polish Journal of Microbiology Q3
Cytotechnology Q3
Biotechnology and Bioprocess Engineering Q3
Compare this journals
Aims and Scope
Nanomedicine
Nanotechnology
Biology
Bioengineering
Drug delivery
Nanotoxicology
Comments